Chemicals · Founded 1972 · www.orientalaromatics.com · BSE 500078 · NSE OAL · ISIN INE959C01023
No Notes Added Yet
Business
Oriental Aromatics Ltd. (OAL) is an India-based company engaged in the manufacturing of aroma chemicals, camphor, and various specialty chemicals. Its core business involves producing ingredients that are primarily used in the fragrance and flavor industry, pharmaceuticals, food & beverages, personal care products, and industrial applications. The company makes money by manufacturing and selling these chemical products to other businesses (B2B model) both domestically and internationally.
Revenue Mix
OAL primarily operates in two main segments:
Aroma Chemicals: This segment includes a wide range of aroma ingredients such as terpineols, terpinyl acetate, pine oil, and various other fragrance and flavor chemicals. These are crucial components for perfumery, soaps, detergents, cosmetics, and food products.
Camphor & Allied Products: OAL is a significant manufacturer of camphor, which has applications in religious ceremonies, pharmaceuticals, and industrial uses. This segment also includes allied products derived from camphor manufacturing.
Specialty Chemicals: The company also produces a portfolio of specialty chemicals catering to diverse industrial applications.
Specific revenue contribution percentages for each segment are not readily available without recent financial reports.
Industry
OAL operates in the Indian chemicals sector, specifically within the aroma chemicals and specialty chemicals sub-segments. The industry is characterized by a mix of organized and unorganized players, with demand driven by growth in end-user industries like FMCG, pharmaceuticals, and food & beverage. OAL is one of the established players in India for aroma chemicals and camphor, benefiting from its manufacturing scale and product portfolio. It faces competition from both domestic manufacturers and international imports. The company emphasizes backward integration (e.g., utilizing pine-based raw materials) to manage costs and ensure supply.
MOAT
Manufacturing Scale & Integration: OAL possesses significant manufacturing capacities for aroma chemicals and camphor, providing economies of scale. Its backward integration strategy for certain raw materials helps in cost control and supply chain stability.
Product Portfolio & R&D: A diversified portfolio of aroma and specialty chemicals, coupled with ongoing R&D efforts, allows OAL to cater to varied customer needs and develop new applications or improve existing products.
Customer Relationships: Long-standing relationships with domestic and international customers in various end-user industries (fragrances, flavors, pharma, etc.) provide a stable demand base.
Process Expertise: Decades of experience in chemical manufacturing processes lead to optimized production, quality control, and efficiency.
Growth Drivers
Growing End-User Industries: Increased consumption of FMCG products (personal care, home care), pharmaceuticals, and packaged foods in India and globally will drive demand for aroma and specialty chemicals.
Capacity Expansions: Any planned or ongoing capacity expansions for existing or new products will enable OAL to capture a larger market share and meet rising demand.
New Product Development & Applications: Successful development and commercialization of new aroma or specialty chemicals, or finding new applications for existing ones, can open up new revenue streams.
Export Opportunities: Leveraging its cost-competitive manufacturing base to increase exports to global markets, especially given geopolitical shifts favoring diversified supply chains.
Shift to Organized Players: A potential shift in demand from unorganized to organized players, driven by quality and regulatory compliance requirements, could benefit OAL.
Risks
Raw Material Price Volatility: Key raw materials (e.g., pine-based derivatives, crude oil derivatives) are subject to global price fluctuations, impacting OAL's cost of production and profitability.
Environmental Regulations: The chemical industry is subject to stringent environmental and safety regulations. Any non-compliance or stricter future regulations could lead to increased operating costs or production disruptions.
Intense Competition: The industry faces competition from both domestic and international players, leading to pricing pressure and potential margin erosion.
Demand Fluctuations: A slowdown in the end-user industries (FMCG, pharma) or changes in consumer preferences for fragrances and flavors could impact demand for OAL's products.
Foreign Exchange Risk: As OAL is involved in exports and imports, adverse movements in foreign currency exchange rates can impact its revenues and costs.
Management & Ownership
Oriental Aromatics Ltd. is part of the Dujodwala Group, with the promoters playing an active role in management. The company has a professional management team with experience in the chemical industry. The promoter group holds a significant stake in the company, aligning their interests with long-term growth. Ownership structure typically shows a high promoter holding, along with institutional and public shareholding.
Outlook
Oriental Aromatics Ltd. operates in a growing segment of the Indian chemical industry, driven by robust demand from FMCG, pharma, and food sectors. Its established manufacturing capabilities, diversified product portfolio, and backward integration offer a degree of resilience and competitive positioning. The company's focus on R&D and potential capacity expansions could fuel future growth. However, OAL remains susceptible to raw material price volatility, intense competition, and evolving environmental regulations. The ability to manage these external factors while capitalizing on domestic consumption growth and export opportunities will be key to its sustained performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 216 | 216 | 237 | 223 | 253 | 226 | 271 | 252 | 282 | 260 |
| Other Income | 2 | 2 | 2 | 0 | 0 | 0 | 3 | 2 | 4 | 1 |
| Total Income | 218 | 217 | 239 | 223 | 253 | 226 | 274 | 254 | 287 | 261 |
| Total Expenditure | 196 | 194 | 208 | 200 | 234 | 207 | 254 | 238 | 263 | 240 |
| Operating Profit | 23 | 24 | 31 | 23 | 20 | 18 | 20 | 15 | 24 | 21 |
| Interest | 3 | 4 | 6 | 6 | 9 | 8 | 10 | 9 | 9 | 8 |
| Depreciation | 5 | 5 | 5 | 6 | 7 | 8 | 8 | 8 | 8 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 15 | 19 | 10 | 4 | 3 | 3 | -2 | 7 | 5 |
| Provision for Tax | 4 | 4 | 4 | 3 | 2 | 2 | 2 | 0 | 3 | 3 |
| Profit After Tax | 10 | 11 | 15 | 7 | 1 | 1 | 1 | -2 | 4 | 3 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 10 | 11 | 15 | 7 | 1 | 1 | 1 | -2 | 4 | 3 |
| Adjusted Earnings Per Share | 3 | 3.3 | 4.4 | 2.1 | 0.4 | 0.1 | 0.2 | -0.6 | 1.2 | 0.7 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 458 | 506 | 755 | 760 | 709 | 869 | 849 | 836 | 928 | 1031 | 1065 |
| Other Income | 8 | 2 | 1 | 7 | 2 | 4 | 6 | 7 | 4 | 10 | 10 |
| Total Income | 466 | 508 | 756 | 767 | 710 | 873 | 855 | 844 | 933 | 1040 | 1076 |
| Total Expenditure | 401 | 442 | 640 | 633 | 554 | 776 | 795 | 789 | 836 | 963 | 995 |
| Operating Profit | 65 | 66 | 116 | 134 | 157 | 97 | 60 | 54 | 96 | 78 | 80 |
| Interest | 6 | 8 | 13 | 12 | 2 | 4 | 13 | 20 | 25 | 36 | 36 |
| Depreciation | 14 | 15 | 18 | 19 | 17 | 17 | 19 | 20 | 24 | 31 | 32 |
| Exceptional Income / Expenses | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 44 | 43 | 83 | 103 | 137 | 76 | 27 | 14 | 48 | 11 | 13 |
| Provision for Tax | 16 | 18 | 26 | 17 | 35 | 23 | 8 | 5 | 13 | 7 | 8 |
| Profit After Tax | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 3 | 6 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 28 | 25 | 57 | 86 | 102 | 53 | 20 | 9 | 34 | 3 | 6 |
| Adjusted Earnings Per Share | 13.6 | 7.4 | 17 | 25.6 | 30.3 | 15.8 | 5.9 | 2.7 | 10.2 | 1 | 1.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 7% | 8% | 0% |
| Operating Profit CAGR | -19% | 9% | -13% | 0% |
| PAT CAGR | -91% | -47% | -51% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 85% | 19% | -7% | 14% |
| ROE Average | 1% | 2% | 4% | 9% |
| ROCE Average | 4% | 5% | 7% | 12% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 317 | 338 | 392 | 464 | 557 | 605 | 625 | 632 | 663 | 665 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 43 | 21 | 12 | 2 | 0 | 45 | 32 | 52 | 74 | 55 |
| Other Non-Current Liabilities | 25 | 28 | 36 | 29 | 29 | 29 | 32 | 33 | 33 | 32 |
| Total Current Liabilities | 106 | 186 | 233 | 114 | 158 | 186 | 298 | 278 | 375 | 443 |
| Total Liabilities | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1145 | 1194 |
| Fixed Assets | 211 | 212 | 245 | 236 | 236 | 265 | 273 | 270 | 480 | 460 |
| Other Non-Current Assets | 21 | 44 | 8 | 9 | 31 | 45 | 74 | 206 | 34 | 31 |
| Total Current Assets | 258 | 317 | 421 | 363 | 477 | 555 | 639 | 518 | 631 | 704 |
| Total Assets | 490 | 573 | 673 | 608 | 745 | 865 | 986 | 995 | 1145 | 1194 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 4 | 5 | 5 | 17 | 15 | 7 | 16 | 11 | 11 |
| Cash Flow from Operating Activities | 0 | 16 | -23 | 181 | 17 | -1 | -22 | 142 | -34 | 2 |
| Cash Flow from Investing Activities | 0 | -31 | -12 | -10 | -35 | -59 | -46 | -99 | -87 | -12 |
| Cash Flow from Financing Activities | 0 | 15 | 36 | -159 | 16 | 51 | 78 | -48 | 121 | 12 |
| Net Cash Inflow / Outflow | 0 | 0 | 0 | 12 | -2 | -9 | 9 | -5 | -0 | 3 |
| Closing Cash & Cash Equivalent | 0 | 5 | 5 | 17 | 15 | 7 | 16 | 11 | 11 | 13 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 13.58 | 7.42 | 16.98 | 25.61 | 30.29 | 15.84 | 5.87 | 2.71 | 10.2 | 0.98 |
| CEPS(Rs) | 20.54 | 11.83 | 22.27 | 31.26 | 35.48 | 20.89 | 11.64 | 8.59 | 17.24 | 10.22 |
| DPS(Rs) | 0.75 | 1 | 1 | 2.5 | 2.5 | 1.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Book NAV/Share(Rs) | 152.53 | 100.31 | 116.46 | 137.92 | 165.6 | 179.84 | 185.7 | 187.9 | 197 | 197.46 |
| Core EBITDA Margin(%) | 12.42 | 12.65 | 15.17 | 16.64 | 21.77 | 10.6 | 6.34 | 5.57 | 9.85 | 6.55 |
| EBIT Margin(%) | 11.01 | 10.03 | 12.68 | 15.04 | 19.55 | 9.16 | 4.75 | 4.09 | 7.79 | 4.48 |
| Pre Tax Margin(%) | 9.65 | 8.49 | 10.97 | 13.48 | 19.23 | 8.7 | 3.22 | 1.67 | 5.09 | 1.04 |
| PAT Margin (%) | 6.09 | 4.94 | 7.54 | 11.29 | 14.31 | 6.11 | 2.31 | 1.08 | 3.67 | 0.32 |
| Cash Profit Margin (%) | 9.22 | 7.87 | 9.88 | 13.78 | 16.76 | 8.06 | 4.59 | 3.43 | 6.21 | 3.31 |
| ROA(%) | 5.69 | 4.7 | 9.17 | 13.45 | 15.07 | 6.62 | 2.13 | 0.92 | 3.21 | 0.28 |
| ROE(%) | 8.9 | 7.68 | 15.67 | 20.14 | 19.96 | 9.17 | 3.21 | 1.45 | 5.3 | 0.5 |
| ROCE(%) | 11.97 | 11.4 | 18.41 | 21.06 | 24.22 | 11.59 | 5.07 | 4.07 | 7.86 | 4.47 |
| Receivable days | 79.84 | 84.59 | 70.87 | 74.46 | 87.1 | 80.17 | 82.27 | 80.29 | 72.03 | 77.47 |
| Inventory Days | 91.26 | 89.18 | 80.82 | 87.33 | 99.89 | 107.6 | 139.96 | 139.73 | 125.3 | 130.92 |
| Payable days | 40.56 | 52.45 | 42.07 | 41.73 | 58.51 | 48.44 | 53.19 | 53.93 | 51.5 | 42.43 |
| PER(x) | 13.37 | 29.29 | 13.37 | 5.23 | 19.37 | 44.56 | 59.96 | 110.54 | 27.03 | 238.87 |
| Price/Book(x) | 1.19 | 2.17 | 1.95 | 0.97 | 3.54 | 3.92 | 1.89 | 1.59 | 1.4 | 1.19 |
| Dividend Yield(%) | 0.21 | 0.23 | 0.44 | 1.86 | 0.43 | 0.21 | 0.14 | 0.17 | 0.18 | 0.21 |
| EV/Net Sales(x) | 1.03 | 1.69 | 1.25 | 0.63 | 2.87 | 2.88 | 1.64 | 1.43 | 1.37 | 1.14 |
| EV/Core EBITDA(x) | 7.29 | 13.07 | 8.09 | 3.59 | 12.97 | 25.84 | 23.28 | 22.1 | 13.14 | 15.18 |
| Net Sales Growth(%) | 0 | 10.55 | 49.14 | 0.69 | -6.72 | 22.57 | -2.27 | -1.49 | 10.98 | 11.05 |
| EBIT Growth(%) | 0 | 0.73 | 89.37 | 19.41 | 21.29 | -42.61 | -49.31 | -15.03 | 111.44 | -36.08 |
| PAT Growth(%) | 0 | -10.42 | 128.74 | 50.83 | 18.27 | -47.71 | -62.96 | -53.89 | 277.06 | -90.36 |
| EPS Growth(%) | 0 | -45.34 | 128.74 | 50.83 | 18.27 | -47.71 | -62.96 | -53.89 | 277.06 | -90.36 |
| Debt/Equity(x) | 0.33 | 0.39 | 0.47 | 0.11 | 0.14 | 0.23 | 0.37 | 0.32 | 0.53 | 0.61 |
| Current Ratio(x) | 2.44 | 1.7 | 1.8 | 3.18 | 3.01 | 2.99 | 2.14 | 1.86 | 1.68 | 1.59 |
| Quick Ratio(x) | 1.36 | 0.99 | 0.93 | 1.76 | 1.58 | 1.44 | 0.91 | 0.87 | 0.71 | 0.73 |
| Interest Cover(x) | 8.11 | 6.5 | 7.4 | 9.63 | 60.28 | 19.76 | 3.11 | 1.69 | 2.89 | 1.3 |
| Total Debt/Mcap(x) | 0.28 | 0.18 | 0.24 | 0.11 | 0.04 | 0.06 | 0.19 | 0.2 | 0.38 | 0.51 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 |
| FII | 0.1 | 0.1 | 0.05 | 0.08 | 0.07 | 0.03 | 0.03 | 0.03 | 0 | 0.02 |
| DII | 0.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.34 | 25.73 | 25.78 | 25.75 | 25.76 | 25.81 | 25.8 | 25.8 | 25.83 | 25.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.85 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +11% | +7% | +8% | — |
| Operating Profit CAGR | -19% | +9% | -13% | — |
| PAT CAGR | -91% | -47% | -51% | — |
| Share Price CAGR | +85% | +19% | -7% | +14% |
| ROE Average | +1% | +2% | +4% | +9% |
| ROCE Average | +4% | +5% | +7% | +12% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 | 74.17 |
| FII | 0.1 | 0.1 | 0.05 | 0.08 | 0.07 | 0.03 | 0.03 | 0.03 | 0 | 0.02 |
| DII | 0.39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.34 | 25.73 | 25.78 | 25.75 | 25.76 | 25.81 | 25.8 | 25.8 | 25.83 | 25.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.85 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 | 3.37 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.